It has been reported that metastasizing tumor cells induce platelets to secrete TGF-β, which inhibits the antitumor activity of natural killer (NK) cells by downregulating the expression of the activating receptor, natural killer group 2 member D (NKG2D), on NK cells [74]. This evidence concerns the gene TGFB1 and neoplasm.